Literature DB >> 16531405

N-terminal region of CCAAT/enhancer-binding protein epsilon is critical for cell cycle arrest, apoptosis, and functional maturation during myeloid differentiation.

Hideaki Nakajima1, Naohide Watanabe, Fumi Shibata, Toshio Kitamura, Yasuo Ikeda, Makoto Handa.   

Abstract

CCAAT/enhancer-binding protein epsilon (C/EBPepsilon) plays a critical role in terminal myeloid differentiation. Differentiation is an integrated process of cell cycle arrest, morphological change, functional maturation, and apoptosis. However, the molecular networks underlying these events in C/EBPepsilon-induced differentiation remain poorly understood. To reveal these mechanisms, we performed a detailed molecular analysis of C/EBPepsilon-induced differentiation using an inducible form of C/EBPepsilon. The activation of C/EBPepsilon induced growth arrest, morphological differentiation, the expression of CD11b and secondary granule proteins, and apoptosis in myeloid cell lines. Unlike C/EBPalpha, C/EBPepsilon dramatically up-regulated p27 with a concomitant down-regulation of cdk4/6 and cyclin D2/A/E. Moreover, the anti-apoptotic proteins Bcl-2 and Bcl-x were down-regulated, whereas pro-apoptotic protein Bax remained unchanged. Using a variety of mutants, we revealed that these events were all regulated by the N-terminal activation domain of C/EBPepsilon. Interestingly, some of the differentiation processes such as the induction of secondary granule protein genes were clearly inhibited by c-Myc; however, inhibition of apoptosis by Bcl-x did not affect the entire differentiation processes. These data indicate the N terminus of C/EBPepsilon to be solely responsible for most aspects of myeloid differentiation, and these events were differentially affected by c-Myc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16531405     DOI: 10.1074/jbc.M600575200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

Authors:  Yogen Saunthararajah; Pierre Triozzi; Brian Rini; Arun Singh; Tomas Radivoyevitch; Mikkael Sekeres; Anjali Advani; Ramon Tiu; Frederic Reu; Matt Kalaycio; Ed Copelan; Eric Hsi; Alan Lichtin; Brian Bolwell
Journal:  Semin Oncol       Date:  2012-02       Impact factor: 4.929

Review 2.  The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis.

Authors:  Shelley M Lawrence; Ross Corriden; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2018-02-07       Impact factor: 11.056

Review 3.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

Review 4.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

5.  A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation.

Authors:  Hanna S Radomska; Finith Jernigan; Sohei Nakayama; Susan E Jorge; Lijun Sun; Daniel G Tenen; Susumu S Kobayashi
Journal:  J Biomol Screen       Date:  2015-06-24

Review 6.  Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.

Authors:  Joshua Yew-Suang Lim; Smita Bhatia; Leslie L Robison; Jun J Yang
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

Review 7.  Ebola: translational science considerations.

Authors:  Francesco Chiappelli; Andre Bakhordarian; April D Thames; Angela M Du; Allison L Jan; Melissa Nahcivan; Mia T Nguyen; Nateli Sama; Ercolano Manfrini; Francesco Piva; Rafael Malagoli Rocha; Carl A Maida
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

8.  Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation.

Authors:  Richa Bedi; Jian Du; Arun K Sharma; Ignatius Gomes; Steven J Ackerman
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

9.  TCEA1 regulates the proliferative potential of mouse myeloid cells.

Authors:  Taomei Yang; Haoran Cui; Mingxin Wen; Johannes Zuber; Scott C Kogan; Guangwei Wei
Journal:  Exp Cell Res       Date:  2018-07-25       Impact factor: 3.905

10.  Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.

Authors:  Carolyn Glass; Charles Wuertzer; Xiaohui Cui; Yingtao Bi; Ramana Davuluri; Ying-Yi Xiao; Michael Wilson; Kristina Owens; Yi Zhang; Archibald Perkins
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.